Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ketoacidosis ...

A case series detailing the association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and a serious side effect of euglycemic diabetic ketoacidosis (DKA) in nine patients, seven of whom ...

A new class of diabetes medications is masking the potentially dangerous condition of ketoacidosis at the time of surgery. Testing for acid load in the blood of diabetes sufferers who are taking ...

Euglycemic diabetic ketoacidosis (EDKA) is characterised by the triad of metabolic acidosis with elevated anion gap, ketonaemia or ketonuria and near-normal blood glucose levels, typically below 200 ...

Diabetic ketoacidosis is a life-threatening complication of diabetes that occurs when the body breaks down fats too quickly. Diabetic ketoacidosis (DKA) occurs in people with diabetes when the body ...